Distribution and partnerships in the UAE and the GCC.
EFBA is seeking licensed distributors, local authorised representatives and pharmacy and clinic chain partners for the IVIXIR series of professional IV formulations in the United Arab Emirates, Saudi Arabia, Kuwait, Qatar, Bahrain and Oman. If you are a licensed distributor looking for an IV formulation supplier for the region, this page explains how we work with partners.
- GMP-certified manufacturing
- CoA, GMP and stability documentation on request
- Country-level exclusivity open to discussion
Who we are looking for
Licensed distributors
Pharmaceutical distribution companies holding a valid wholesale or drug-store licence in their country, with access to clinics, hospitals and pharmacies.
Local authorised representatives
Locally licensed companies able to act as the local representative and marketing authorisation holder for product registration in their market.
Pharmacy and clinic chains
Groups operating several pharmacies, clinics or medical centres that want a direct, documented supply relationship.
Registration: the role of the local partner
In the UAE, medical products are registered with the Emirates Drug Establishment (EDE), the federal authority responsible for medical product registration, and a product cannot be marketed in the country without it. The application is filed by a locally licensed company acting as the local representative, which holds the registration-facing role and the in-country licences.
EFBA prepares the technical registration dossier — composition, manufacturing, quality and stability data — and supports the partner through each submission and query. The other GCC markets follow their own national procedures (for example, the Saudi Food and Drug Authority in Saudi Arabia), and the same division of roles applies.
The registration status of individual products differs by country and is discussed directly with qualified partners; no registration status is stated on this website.
What EFBA provides to partners
- Manufacturing. GMP-certified manufacturing with batch traceability.
- Documentation. Certificate of analysis per batch, GMP certificate and stability data, available to qualified partners on request (usually under a confidentiality agreement).
- Registration support. A complete technical dossier and responses to regulator queries, prepared by EFBA for the local partner.
- Cold chain. Storage and shipping conditions defined for each product; temperature-controlled logistics agreed with the partner.
- Commercial terms. Country-level exclusivity can be discussed. Minimum order quantities and pricing are shared with approved partners only.
How a partnership starts
Enquiry
Send the enquiry form with "Distribution / Supply" selected and tell us your country, licences and channels.
Qualification call
An online meeting to review your licences, territory, customer base and storage and distribution capability.
Documentation and regulatory review
We share CoA, GMP and stability documentation and agree a registration plan for your market.
Agreement
Territory, exclusivity, minimum order quantities, pricing and logistics are set out in a written distribution agreement.
The ideal partner
- A valid pharmaceutical distribution licence in the target country.
- Established relationships with clinics, hospitals, medical centres or pharmacies.
- Temperature-controlled storage and distribution capability.
- Regulatory affairs experience with the EDE, the SFDA or an equivalent authority — or the readiness to act as local representative.
- A commitment to compliant, claim-free promotion to healthcare professionals.
Apply as a partner
Use the enquiry form and choose "Distribution / Supply". Tell us your country, licences and the channels you serve; our team replies within two working days.
Partner FAQ
Which countries are you looking for partners in?
The United Arab Emirates, Saudi Arabia, Kuwait, Qatar, Bahrain and Oman. Enquiries from other markets in the region are reviewed case by case.
Are IVIXIR products registered in the UAE?
Registration status differs by product and by country, and we discuss it directly with qualified partners. In the UAE, registration is filed with the Emirates Drug Establishment (EDE) by a locally licensed representative; EFBA prepares and supports the dossier.
Can we have exclusivity for our country?
Country-level exclusivity is open to discussion. It is usually linked to registration responsibility in that market and to agreed volumes.
What documentation can you provide?
A certificate of analysis per batch, the GMP certificate and stability data. They are available to qualified partners on request, usually under a confidentiality agreement.
What are the minimum order quantities and prices?
There is no public price list. Minimum order quantities and pricing are shared with approved partners after the qualification call.
How are temperature-sensitive products shipped?
Each product has defined storage and shipping conditions, and temperature-controlled logistics are agreed with the partner before the first shipment.
This page describes partnership terms for licensed businesses. It is not an offer to the public and makes no claim about the registration status, use or effect of any product.